Developer docs
API playgroundTry for free, no card

Search company profiles

University of California, San Francisco

Full company profile

uuid00022uu

Namestring
University of California, San Francisco
Legal namestring
The Regents of the University of California
Websiteurl
ucsf.edu
Company typeenum
Public
Founded yearint
1868
Descriptiontext

The University of California, San Francisco (UCSF) is a public research university and academic medical center dedicated exclusively to the health sciences, operating as a campus of the University of California system under the governance of The Regents of the University of California. Founded in 1864 and headquartered in San Francisco with more than 10,000 employees, UCSF operates across four professional schools (Medicine, Nursing, Pharmacy, Dentistry), a graduate division, the UCSF Health hospital and clinic network (including UCSF Medical Center, UCSF Benioff Children's Hospitals, UCSF Dental Center, and Langley Porter Psychiatric Hospital and Clinics), and Global Health Sciences. The institution consistently ranks among the top 10 U.S. hospitals and is the leading recipient of National Institutes of Health research funding.

UCSF's core technology base spans biomedical research domains including AI/ML for healthcare, CRISPR gene editing, genomics, brain-computer interfaces, single-cell analysis, organoid development, and psychedelic medicine. Notable proprietary technologies include the MaxToki transformer-based model trained on roughly one trillion gene tokens from approximately 197 million single-cell transcriptomes for cellular aging prediction, the Mirai AI mammography risk model, the MiniDock MTB portable tuberculosis testing device, an adaptive closed-loop brain implant for Parkinson's disease, an in-vivo CAR-T cell therapy platform developed with the Gladstone Institutes, and high-throughput robotic platforms for cancer persister cell research. Major technology and research partners include OpenAI, NVIDIA, Arc Institute, SandboxAQ, and Microsoft.

UCSF's revenue model rests on four streams: patient care services delivered through UCSF Health hospitals and specialty clinics; tuition and fees from professional and graduate health sciences programs; sponsored research funded primarily through NIH grants (with $81 million for the National Dementia Workforce Study and $151 million for the Alzheimer's Tau Platform as recent examples); and philanthropy, including a $100 million commitment from the Weill family to establish a Stanford-UCSF cancer hub and a $100 million grant from the OpenAI Foundation for Alzheimer's research. Patient acquisition occurs through clinical reputation and referrals, student recruitment through academic standing, and research funding through federal grants and private foundations. Customer segments span individual patients, health sciences students, faculty/researchers, and partner institutions such as Zuckerberg San Francisco General Hospital and Mount Sinai Tisch Cancer Center.

Short descriptiontext

The University of California, San Francisco is a public academic medical center operating UCSF Health hospitals and specialty clinics, four professional health sciences schools, and a leading NIH-funded biomedical research enterprise serving patients, students, and faculty.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
academic medical center, medical education programs, biomedical research services, patient care services, clinical trials research
Industry4 codes
1Public Research Universities with Academic Medical Centers (AMCs)
CodeEDAHAAACPrimaryYes
2Academic Medical Centers & Teaching Hospitals (University-Affiliated)
CodeEDAHAGAAPrimaryNo
3Biomedical Sciences & Medical Research Institutes (University-Based)
CodeEDAHAGAIPrimaryNo
4Medical Schools (MD/DO Granting)
CodeEDAHAGABPrimaryNo
NAICS code2 codes
  • Colleges, Universities, and Professional Schools611310
  • General Medical and Surgical Hospitals6221
SIC code1 code
  • Services-Health Services8000
Product category
Academic Medical Center
Social media profiles5 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Patient Care Services
TypeSubscription Recurring
Description

UCSF Health provides comprehensive medical services through its hospitals and clinics, generating revenue from patient care, procedures, and hospital services

ucsf.edu
2Education and Training
TypeSubscription Recurring
Description

Tuition and fees from medical, dental, nursing, pharmacy, and graduate programs across UCSF's professional schools

ucsf.edu
3Sponsored Research
TypeManaged Services
Description

Federal grants primarily from NIH along with other government agencies and private foundations fund research activities

news.umich.edu
4Philanthropy
TypeLicensing Royalties
Description

Private donations and grants from foundations and individuals supporting research and institutional priorities

economictimes.indiatimes.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

University of California, San Francisco is a public research university and academic medical center delivering integrated health sciences education, biomedical research, and patient care services. It operates UCSF Health hospitals and clinics, four professional schools (Medicine, Nursing, Pharmacy, Dentistry), and develops proprietary medical technologies including AI diagnostic models, medical devices, and therapeutic platforms. Revenue is generated through patient care, tuition, sponsored research, philanthropy, and technology licensing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Top-10 national hospital ranking
+2 more records
Product overview1 text field

University of California, San Francisco is an academic medical center comprising UCSF Health (hospitals, specialty clinics, and dental center), four professional schools (Medicine, Nursing, Pharmacy, Dentistry), and Global Health Sciences. UCSF also develops and licenses technology innovations including AI diagnostic tools (Mirai AI for breast cancer screening, MaxToki for cellular aging prediction), medical devices (MiniDock MTB portable TB test), and research platforms (in vivo CAR-T therapy, TemPredict wearable health monitoring). These products span clinical care delivery, educational programs, and research innovations that are licensed to biotechnology and pharmaceutical partners.

Product and service16 records
1UCSF Health
CategoryHealthcare services
Description

Integrated health system providing patient care across multiple hospitals and specialty clinics, including UCSF Medical Center, UCSF Benioff Children's Hospitals, UCSF Dental Center, and Langley Porter Psychiatric Hospital and Clinics. Serves patients seeking advanced, specialized medical care across all medical specialties.

2UCSF School of Medicine
CategoryEducational program
Description

Medical school offering MD programs, graduate medical education, and continuing medical education for healthcare professionals pursuing medical training and careers.

3UCSF School of Nursing
CategoryEducational program
Description

Nursing school providing undergraduate, graduate, and continuing education programs for nursing professionals across the full career continuum.

4UCSF School of Pharmacy
CategoryEducational program
Description

Pharmacy school offering PharmD and graduate programs in pharmaceutical sciences and clinical pharmacy for pharmacists and pharmaceutical scientists.

5UCSF School of Dentistry
CategoryEducational program and healthcare service
Description

Dental school and clinical practice providing oral healthcare services alongside dental education programs for dentists and dental specialists.

6UCSF Benioff Children's Hospitals
CategoryHealthcare service
Description

Pediatric healthcare services delivered through UCSF Benioff Children's Hospitals, providing specialized care for infants, children, and adolescents including neonatal services.

7UCSF Dental Center
CategoryHealthcare service
Description

Clinical dental care service providing oral healthcare to patients, staffed by faculty and trainees from the UCSF School of Dentistry.

8Langley Porter Psychiatric Hospital and Clinics
CategoryHealthcare service
Description

Psychiatric hospital and outpatient clinics providing mental health evaluation, treatment, and specialty psychiatric care to patients.

9UCSF Global Health Sciences
CategoryEducational program
Description

Educational and research program focused on global health, offering training and conducting research on health challenges affecting populations worldwide.

10Clinical Trials Program
CategoryResearch service
Description

Clinical trials program offering patient enrollment in sponsored research protocols, including the National Dementia Workforce Study and other investigational studies of new treatments and diagnostics.

11MaxToki AI Model
CategoryAI research platform
Description

Transformer-based AI model trained on approximately 1 trillion gene tokens from 197 million single-cell transcriptomes to predict cellular aging trajectories across the human lifespan, with median prediction error of 87 months. Developed with Gladstone Institutes, NVIDIA, and Arc Institute.

12Mirai AI
CategoryAI diagnostic tool
Description

Open-source AI model that identifies high-risk breast cancer patients from screening mammograms, flagging approximately 12.7% of patients as high-risk for same-day imaging and biopsies and completing evaluations in about an hour.

13MiniDock MTB
CategoryMedical device
Description

Portable, battery-powered tuberculosis testing device that delivers results in under 30 minutes with accuracy matching traditional laboratory testing using molecular technology to detect TB DNA from tongue swabs.

14Adaptive Brain Implant
CategoryMedical device
Description

Personalized brain implant for Parkinson's disease providing real-time electrical stimulation that detects neural signals associated with each step and automatically adjusts pulses within fractions of a second, improving gait symmetry, walking patterns, and reducing fall risk.

15In-Vivo CAR-T Cell Therapy Platform
CategoryResearch platform
Description

Research platform for a method to create cancer-fighting cells directly inside the body, eliminating the need for complex laboratory-based CAR-T cell therapy processes. Successfully treated aggressive leukemia, multiple myeloma, and solid tumors in mice with humanized immune systems.

16OpenAI for Healthcare at UCSF
CategoryAI clinical workflow platform
Description

HIPAA-compliant AI suite powered by GPT-5.2 models deployed at UCSF for clinical workflows including diagnosis assistance, evidence retrieval with transparent citations, reusable templates, and administrative task automation, with Business Associate Agreement (BAA) support and content not used for model training.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership21 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-06-26
Description

Long COVID research identifying mannosylated extracellular vesicles as potential therapeutic target for Hemopurifier device.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-04
Description

Collaborative research program testing glioprotective small molecule drug compounds designed to protect glial cells in ALS patients.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-13
Description

Development of dual-feature CAR-T cells for HIV treatment, enabling patients to suppress virus for nearly two years.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-12
Description

Largest omics characterization of cutaneous squamous cell carcinoma involving 366 tumors for RNA-sequencing.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-06
Description

Collaboration on combination immunotherapy strategy to overcome resistance in colorectal cancer, achieving up to 100% tumor clearance.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-05
Description

Development of MaxToki AI model for predicting cellular aging trajectories using single-cell transcriptomics.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-05
Description

Technical collaboration on AI model training infrastructure for MaxToki and other computational biology applications.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-04-05
Description

Multi-institutional AI research collaboration developing models for cellular aging and disease prediction.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-02
Description

OMRON-AF Trial evaluating early detection of atrial fibrillation using home blood pressure monitoring in 1,900 hypertension patients.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-01
Description

Support for Carhart-Harris Lab psychedelic research via Filament Health's pharmaceutical-grade botanical psilocybin candidate.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-01
Description

Supplying PEX010 psilocybin for CHL Global Psychedelic Study; has supplied to over 70 trials worldwide.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-26
Description

Joint development of in-vivo CAR-T cell therapy method to create cancer-fighting cells directly inside the body.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-03-24
Description

$1.35M initial funding for VIPER program to validate diagnostic tests for Long COVID biological drivers.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-05
Description

Development of Evo 2 AI model trained on over 128,000 genomes capable of identifying disease-causing mutations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-18
Description

Research collaboration exploring NKTR-0165, a novel TNFR2 agonist antibody, in multiple sclerosis models led by Dr. Stephen Hauser.

16University of Virginia School of Data Science
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-27
Description

$4.7M AI-powered diabetes management project combining adaptive ML algorithms with ultra-rapid-acting insulin delivery.

news-medical.net
Strategic tierMajorTypeTechnology or IntegrationAnnounced on2026-01-10
Description

HIPAA-compliant AI suite deployment with GPT-5.2 models for clinical workflows, evidence retrieval, and documentation automation.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-01-10
Description

Early adopter of OpenAI's HIPAA-compliant healthcare AI products for clinical documentation and workflow automation.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-01-06
Description

280,000 square foot lease at South San Francisco campus for UCSF research and operations expansion, strengthening presence in biotech hub.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-20
Description

Collaboration using large quantitative AI models (AQBioSim platform) to compress neurodegenerative disease research timelines.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-03
Description

National Dementia Workforce Study, an $81 million NIH-funded project surveying healthcare workers to improve dementia care understanding.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Stanford Medicine is the Bay Area's other top-tier academic medical center and research university, with a parallel mix of NIH-leading research, a major hospital system, and AI/health-tech partnerships. It is UCSF's closest geographic and functional peer and the explicit co-collaborator on the $100M Weill Family cancer hub.

TypeDirect peer
Description

Johns Hopkins is a perennial #1/#2 U.S. academic medical center with a comparable structure of research-intensive medicine, professional schools, and a multi-hospital health system. It competes with UCSF for NIH funding, faculty talent, and top hospital rankings.

TypeDirect peer
Description

Mass General and Harvard Medical School form a leading academic medical enterprise comparable to UCSF in NIH funding scale, clinical reputation, biomedical AI research, and integrated teaching-hospital structure. Both compete for top-tier faculty, trainees, and sponsored research.

TypeDirect peer
Description

Mayo Clinic is a top-3 nationally ranked hospital system with an integrated research and education mission similar to UCSF Health's, operating a multi-site clinical enterprise with deep sponsored-research activity. It competes for complex-case referrals, talent, and research funding.

TypeDirect peer
Description

UCLA Health is the other major UC system academic medical center and a direct peer on research output, hospital ranking, NIH funding, and California-based patient referrals. It is governed by the same UC Regents, making it the closest institutional analog within the UC system.

TypeDirect peer
Description

Cedars-Sinai is a top-10 U.S. hospital with an affiliated research institute and significant translational AI/biomedical programs. It competes directly with UCSF Health for complex-case referrals in California and for sponsored research dollars.

TypeDirect peer
Description

UC San Diego Health is another UC system academic medical center with comparable research, education, and clinical-care activities. It competes with UCSF for NIH funding allocations, faculty recruitment, and California patient volumes.

TypeDirect peer
Description

Weill Cornell is an Ivy League biomedical research institution with an affiliated hospital (NewYork-Presbyterian), comparable in research prestige, NIH funding scale, and medical-school structure. It competes with UCSF for top faculty and sponsored research.

TypeDirect peer
Description

NYU Langone is a top-tier academic medical center integrating medical school, hospital system, and significant research output. It parallels UCSF in scale, AI-in-medicine initiatives, and ability to attract major grants and philanthropy.

TypeDirect peer
Description

Duke combines a leading medical school, NIH-funded biomedical research, and a multi-hospital system—structurally similar to UCSF. It is a comparable peer for research funding rankings, faculty recruiting, and clinical excellence benchmarks.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability15 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

University of California, San Francisco

Academic Medical Centerucsf.edu

The University of California, San Francisco is a public academic medical center operating UCSF Health hospitals and specialty clinics, four professional health sciences schools, and a leading NIH-funded biomedical research enterprise serving patients, students, and faculty.

What University of California, San Francisco does

The University of California, San Francisco (UCSF) is a public research university and academic medical center dedicated exclusively to the health sciences, operating as a campus of the University of California system under the governance of The Regents of the University of California. Founded in 1864 and headquartered in San Francisco with more than 10,000 employees, UCSF operates across four professional schools (Medicine, Nursing, Pharmacy, Dentistry), a graduate division, the UCSF Health hospital and clinic network (including UCSF Medical Center, UCSF Benioff Children's Hospitals, UCSF Dental Center, and Langley Porter Psychiatric Hospital and Clinics), and Global Health Sciences. The institution consistently ranks among the top 10 U.S. hospitals and is the leading recipient of National Institutes of Health research funding.

UCSF's core technology base spans biomedical research domains including AI/ML for healthcare, CRISPR gene editing, genomics, brain-computer interfaces, single-cell analysis, organoid development, and psychedelic medicine. Notable proprietary technologies include the MaxToki transformer-based model trained on roughly one trillion gene tokens from approximately 197 million single-cell transcriptomes for cellular aging prediction, the Mirai AI mammography risk model, the MiniDock MTB portable tuberculosis testing device, an adaptive closed-loop brain implant for Parkinson's disease, an in-vivo CAR-T cell therapy platform developed with the Gladstone Institutes, and high-throughput robotic platforms for cancer persister cell research. Major technology and research partners include OpenAI, NVIDIA, Arc Institute, SandboxAQ, and Microsoft.

UCSF's revenue model rests on four streams: patient care services delivered through UCSF Health hospitals and specialty clinics; tuition and fees from professional and graduate health sciences programs; sponsored research funded primarily through NIH grants (with $81 million for the National Dementia Workforce Study and $151 million for the Alzheimer's Tau Platform as recent examples); and philanthropy, including a $100 million commitment from the Weill family to establish a Stanford-UCSF cancer hub and a $100 million grant from the OpenAI Foundation for Alzheimer's research. Patient acquisition occurs through clinical reputation and referrals, student recruitment through academic standing, and research funding through federal grants and private foundations. Customer segments span individual patients, health sciences students, faculty/researchers, and partner institutions such as Zuckerberg San Francisco General Hospital and Mount Sinai Tisch Cancer Center.

University of California, San Francisco firmographics

Firmographics
Name
University of California, San Francisco
Legal name
The Regents of the University of California
Website
https://ucsf.edu
Company type
Public
Founded year
1868
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
The University of California, San Francisco is a public academic medical center operating UCSF Health hospitals and specialty clinics, four professional health sciences schools, and a leading NIH-funded biomedical research enterprise serving patients, students, and faculty.
Ownership category
akta.pro rank

University of California, San Francisco industry classification

Industry
Product category
Academic Medical Center
NAICS
Colleges, Universities, and Professional Schools (611310), General Medical and Surgical Hospitals (6221)
SIC
Services-Health Services (8000)
akta.pro primary industry
Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)
akta.pro secondary industries
Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Medical Schools (MD/DO Granting) (EDAHAGAB)

Keywords

  • Academic medical center
  • Medical education programs
  • Biomedical research services
  • Patient care services
  • Clinical trials research

Where University of California, San Francisco is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices4 records

Markets served

University of California, San Francisco business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Patient Care Services: UCSF Health provides comprehensive medical services through its hospitals and clinics, generating revenue from patient care, procedures, and hospital services
  2. Education and Training: Tuition and fees from medical, dental, nursing, pharmacy, and graduate programs across UCSF's professional schools
  3. Sponsored Research: Federal grants primarily from NIH along with other government agencies and private foundations fund research activities
  4. Philanthropy: Private donations and grants from foundations and individuals supporting research and institutional priorities

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

University of California, San Francisco product offering

Product offering

Core offering

University of California, San Francisco is a public research university and academic medical center delivering integrated health sciences education, biomedical research, and patient care services. It operates UCSF Health hospitals and clinics, four professional schools (Medicine, Nursing, Pharmacy, Dentistry), and develops proprietary medical technologies including AI diagnostic models, medical devices, and therapeutic platforms. Revenue is generated through patient care, tuition, sponsored research, philanthropy, and technology licensing.

Product overview

University of California, San Francisco is an academic medical center comprising UCSF Health (hospitals, specialty clinics, and dental center), four professional schools (Medicine, Nursing, Pharmacy, Dentistry), and Global Health Sciences. UCSF also develops and licenses technology innovations including AI diagnostic tools (Mirai AI for breast cancer screening, MaxToki for cellular aging prediction), medical devices (MiniDock MTB portable TB test), and research platforms (in vivo CAR-T therapy, TemPredict wearable health monitoring). These products span clinical care delivery, educational programs, and research innovations that are licensed to biotechnology and pharmaceutical partners.

Differentiator

Problem solved

Functional benefit

Products and services

  • UCSF Health Integrated health system providing patient care across multiple hospitals and specialty clinics, including UCSF Medical Center, UCSF Benioff Children's Hospitals, UCSF Dental Center, and Langley Porter Psychiatric Hospital and Clinics. Serves patients seeking advanced, specialized medical care across all medical specialties.
  • UCSF School of Medicine Medical school offering MD programs, graduate medical education, and continuing medical education for healthcare professionals pursuing medical training and careers.
  • UCSF School of Nursing Nursing school providing undergraduate, graduate, and continuing education programs for nursing professionals across the full career continuum.
  • UCSF School of Pharmacy Pharmacy school offering PharmD and graduate programs in pharmaceutical sciences and clinical pharmacy for pharmacists and pharmaceutical scientists.
  • UCSF School of Dentistry Dental school and clinical practice providing oral healthcare services alongside dental education programs for dentists and dental specialists.
  • UCSF Benioff Children's Hospitals Pediatric healthcare services delivered through UCSF Benioff Children's Hospitals, providing specialized care for infants, children, and adolescents including neonatal services.
  • UCSF Dental Center Clinical dental care service providing oral healthcare to patients, staffed by faculty and trainees from the UCSF School of Dentistry.
  • Langley Porter Psychiatric Hospital and Clinics Psychiatric hospital and outpatient clinics providing mental health evaluation, treatment, and specialty psychiatric care to patients.
  • UCSF Global Health Sciences Educational and research program focused on global health, offering training and conducting research on health challenges affecting populations worldwide.
  • Clinical Trials Program Clinical trials program offering patient enrollment in sponsored research protocols, including the National Dementia Workforce Study and other investigational studies of new treatments and diagnostics.
  • MaxToki AI Model Transformer-based AI model trained on approximately 1 trillion gene tokens from 197 million single-cell transcriptomes to predict cellular aging trajectories across the human lifespan, with median prediction error of 87 months. Developed with Gladstone Institutes, NVIDIA, and Arc Institute.
  • Mirai AI Open-source AI model that identifies high-risk breast cancer patients from screening mammograms, flagging approximately 12.7% of patients as high-risk for same-day imaging and biopsies and completing evaluations in about an hour.
  • MiniDock MTB Portable, battery-powered tuberculosis testing device that delivers results in under 30 minutes with accuracy matching traditional laboratory testing using molecular technology to detect TB DNA from tongue swabs.
  • Adaptive Brain Implant Personalized brain implant for Parkinson's disease providing real-time electrical stimulation that detects neural signals associated with each step and automatically adjusts pulses within fractions of a second, improving gait symmetry, walking patterns, and reducing fall risk.
  • In-Vivo CAR-T Cell Therapy Platform Research platform for a method to create cancer-fighting cells directly inside the body, eliminating the need for complex laboratory-based CAR-T cell therapy processes. Successfully treated aggressive leukemia, multiple myeloma, and solid tumors in mice with humanized immune systems.
  • OpenAI for Healthcare at UCSF HIPAA-compliant AI suite powered by GPT-5.2 models deployed at UCSF for clinical workflows including diagnosis assistance, evidence retrieval with transparent citations, reusable templates, and administrative task automation, with Business Associate Agreement (BAA) support and content not used for model training.

Quantifiable outcome

  • Top-10 national hospital ranking
  • +2 more outcomes

Companies that use University of California, San Francisco

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

University of California, San Francisco technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability15 records

Feature7 records

University of California, San Francisco partnerships and signals

Strategic signal

Partnerships

21 partnerships are on record, tiered minor, core and major.

  • Aethlon MedicalminorStrategic or Co-development Partner · 26 June 2026Long COVID research identifying mannosylated extracellular vesicles as potential therapeutic target for Hemopurifier device.
  • ALS NorthwestcoreStrategic or Co-development Partner · 4 June 2026Collaborative research program testing glioprotective small molecule drug compounds designed to protect glial cells in ALS patients.
  • Caring CrosscoreStrategic or Co-development Partner · 13 May 2026Development of dual-feature CAR-T cells for HIV treatment, enabling patients to suppress virus for nearly two years.
  • SkylineDxminorStrategic or Co-development Partner · 12 May 2026Largest omics characterization of cutaneous squamous cell carcinoma involving 366 tumors for RNA-sequencing.
  • Mount Sinai Tisch Cancer CentercoreStrategic or Co-development Partner · 6 May 2026Collaboration on combination immunotherapy strategy to overcome resistance in colorectal cancer, achieving up to 100% tumor clearance.
  • Gladstone InstitutescoreStrategic or Co-development Partner · 5 April 2026Development of MaxToki AI model for predicting cellular aging trajectories using single-cell transcriptomics.
  • NVIDIAcoreTechnology or Integration · 5 April 2026Technical collaboration on AI model training infrastructure for MaxToki and other computational biology applications.
  • Arc InstitutemajorStrategic or Co-development Partner · 5 April 2026Multi-institutional AI research collaboration developing models for cellular aging and disease prediction.
  • OMRON HealthcarecoreStrategic or Co-development Partner · 2 April 2026OMRON-AF Trial evaluating early detection of atrial fibrillation using home blood pressure monitoring in 1,900 hypertension patients.
  • Red Light HollandminorStrategic or Co-development Partner · 1 April 2026Support for Carhart-Harris Lab psychedelic research via Filament Health's pharmaceutical-grade botanical psilocybin candidate.
  • Filament HealthminorStrategic or Co-development Partner · 1 April 2026Supplying PEX010 psilocybin for CHL Global Psychedelic Study; has supplied to over 70 trials worldwide.
  • Gladstone InstitutescoreStrategic or Co-development Partner · 26 March 2026Joint development of in-vivo CAR-T cell therapy method to create cancer-fighting cells directly inside the body.
  • PolyBio Research FoundationmajorStrategic or Co-development Partner · 24 March 2026$1.35M initial funding for VIPER program to validate diagnostic tests for Long COVID biological drivers.
  • Arc Institute and NVIDIAcoreTechnology or Integration · 5 March 2026Development of Evo 2 AI model trained on over 128,000 genomes capable of identifying disease-causing mutations.
  • Nektar TherapeuticscoreStrategic or Co-development Partner · 18 February 2026Research collaboration exploring NKTR-0165, a novel TNFR2 agonist antibody, in multiple sclerosis models led by Dr. Stephen Hauser.
  • University of Virginia School of Data ScienceminorStrategic or Co-development Partner · 27 January 2026$4.7M AI-powered diabetes management project combining adaptive ML algorithms with ultra-rapid-acting insulin delivery.
  • OpenAImajorTechnology or Integration · 10 January 2026HIPAA-compliant AI suite deployment with GPT-5.2 models for clinical workflows, evidence retrieval, and documentation automation.
  • HCA HealthcaremajorStrategic or Co-development Partner · 10 January 2026Early adopter of OpenAI's HIPAA-compliant healthcare AI products for clinical documentation and workflow automation.
  • Kilroy RealtymajorStrategic or Co-development Partner · 6 January 2026280,000 square foot lease at South San Francisco campus for UCSF research and operations expansion, strengthening presence in biotech hub.
  • SandboxAQcoreTechnology or Integration · 20 December 2025Collaboration using large quantitative AI models (AQBioSim platform) to compress neurodegenerative disease research timelines.
  • University of MichigancoreStrategic or Co-development Partner · 3 October 2023National Dementia Workforce Study, an $81 million NIH-funded project surveying healthcare workers to improve dementia care understanding.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

University of California, San Francisco competitors and assessment

Company assessment

Direct peers

  • Stanford Medicine: Stanford Medicine is the Bay Area's other top-tier academic medical center and research university, with a parallel mix of NIH-leading research, a major hospital system, and AI/health-tech partnerships. It is UCSF's closest geographic and functional peer and the explicit co-collaborator on the $100M Weill Family cancer hub.
  • Johns Hopkins Medicine: Johns Hopkins is a perennial #1/#2 U.S. academic medical center with a comparable structure of research-intensive medicine, professional schools, and a multi-hospital health system. It competes with UCSF for NIH funding, faculty talent, and top hospital rankings.
  • Massachusetts General Hospital / Harvard Medical School: Mass General and Harvard Medical School form a leading academic medical enterprise comparable to UCSF in NIH funding scale, clinical reputation, biomedical AI research, and integrated teaching-hospital structure. Both compete for top-tier faculty, trainees, and sponsored research.
  • Mayo Clinic: Mayo Clinic is a top-3 nationally ranked hospital system with an integrated research and education mission similar to UCSF Health's, operating a multi-site clinical enterprise with deep sponsored-research activity. It competes for complex-case referrals, talent, and research funding.
  • UCLA Health (David Geffen School of Medicine): UCLA Health is the other major UC system academic medical center and a direct peer on research output, hospital ranking, NIH funding, and California-based patient referrals. It is governed by the same UC Regents, making it the closest institutional analog within the UC system.
  • Cedars-Sinai Medical Center: Cedars-Sinai is a top-10 U.S. hospital with an affiliated research institute and significant translational AI/biomedical programs. It competes directly with UCSF Health for complex-case referrals in California and for sponsored research dollars.
  • UC San Diego Health: UC San Diego Health is another UC system academic medical center with comparable research, education, and clinical-care activities. It competes with UCSF for NIH funding allocations, faculty recruitment, and California patient volumes.
  • Weill Cornell Medicine: Weill Cornell is an Ivy League biomedical research institution with an affiliated hospital (NewYork-Presbyterian), comparable in research prestige, NIH funding scale, and medical-school structure. It competes with UCSF for top faculty and sponsored research.
  • NYU Langone Health: NYU Langone is a top-tier academic medical center integrating medical school, hospital system, and significant research output. It parallels UCSF in scale, AI-in-medicine initiatives, and ability to attract major grants and philanthropy.
  • Duke University Health System: Duke combines a leading medical school, NIH-funded biomedical research, and a multi-hospital system—structurally similar to UCSF. It is a comparable peer for research funding rankings, faculty recruiting, and clinical excellence benchmarks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

University of California, San Francisco social profiles

Digital presence

University of California, San Francisco compliance and trust

Trust signal

Compliance1 record

University of California, San Francisco financial estimates

Financial estimate

Revenue estimate

Valuation estimate

University of California, San Francisco leadership team

Management profile

Number of profiles

Profiles6 records

University of California, San Francisco subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

University of California, San Francisco funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

University of California, San Francisco M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of California, San Francisco

What does University of California, San Francisco do?

University of California, San Francisco is a public research university and academic medical center delivering integrated health sciences education, biomedical research, and patient care services. It operates UCSF Health hospitals and clinics, four professional schools (Medicine, Nursing, Pharmacy, Dentistry), and develops proprietary medical technologies including AI diagnostic models, medical devices, and therapeutic platforms. Revenue is generated through patient care, tuition, sponsored research, philanthropy, and technology licensing.

Is University of California, San Francisco a public or private company?

University of California, San Francisco is a public company. It is classified as state government owned and is currently operating.

When was University of California, San Francisco founded?

University of California, San Francisco was founded in 1868. It employs 5,001 to 10,000 people.

Where is University of California, San Francisco based?

University of California, San Francisco is headquartered in San Francisco, United States, in the North America region.

How does University of California, San Francisco make money?

Four revenue lines are on record. Patient Care Services are the primary driver. The others are education and Training, sponsored Research and philanthropy.

Who are University of California, San Francisco's main competitors?

Direct peers on record are Stanford Medicine, Johns Hopkins Medicine, Massachusetts General Hospital / Harvard Medical School, Mayo Clinic, UCLA Health (David Geffen School of Medicine), Cedars-Sinai Medical Center, UC San Diego Health, Weill Cornell Medicine, NYU Langone Health and Duke University Health System.

Does University of California, San Francisco have an API?

No public API is recorded for University of California, San Francisco.

What industry is University of California, San Francisco in?

University of California, San Francisco's product category is Academic Medical Center. Its primary akta.pro industry code is EDAHAAAC, Public Research Universities with Academic Medical Centers (AMCs), with a secondary code of EDAHAGAA, Academic Medical Centers & Teaching Hospitals (University-Affiliated). Its NAICS code is 611310 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewsfileRhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Licence Agreement with the University of California, San Francisco for a Phase 2 Trial of Psilocybin in Methamphetamine Use DisordeRhelion Life Sciences' subsidiary Filament Health signed a licence and supply agreement with UCSF to provide PEX010 for a Phase 2 trial of psilocybin in methamphetamine use disorder among people living with HIV. The trial will enroll 30 participants, with dosing at 25 mg or 5 mg, and is expected to begin in November 2026.AktienRhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Licence Agreement with the University of California, San Francisco for a Phase 2 Trial of Psilocybin in Methamphetamine Use Disorder Among People with HIVFilament Health, a wholly owned subsidiary of Rhelion Life Sciences, signed a licence and supply agreement with UCSF for PEX010 in a Phase 2 trial of psilocybin for methamphetamine use disorder among people with HIV. The trial will enroll 30 participants, with dosing at 25 mg or 5 mg, and is expected to begin in November 2026.YahooRhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Licence Agreement with the University of California, San Francisco for a Phase 2 Trial of Psilocybin in Methamphetamine Use Disorder Among People with HIVFilament Health, a wholly owned subsidiary of Rhelion Life Sciences, signed a licence agreement with UCSF to supply PEX010 for a Phase 2 trial of psilocybin in methamphetamine use disorder among people living with HIV. The PRISM trial will enroll 30 participants, with dosing at 25 mg or 5 mg, and is expected to begin in November 2026.Local BreakingAutism: Scientists develop largest 'map' in search for therapiesResearchers at the University of California, San Francisco, published a molecular map of autism in Science, using AI and lab-grown brain organoids to chart over 1,800 autism-linked protein-protein interactions, 87% of which were previously unseen. The study, which focuses mainly on profound autism, could guide therapies targeting disrupted protein complexes rather than individual genes.FinancialContent Business PageSuffolk and CO Architects Selected to Deliver University of California, San Francisco Mission Bay Education Center and Dental Clinics ProjectSuffolk and CO Architects have been selected to deliver the University of California, San Francisco Mission Bay Education Center and Dental Clinics project through a progressive design-build delivery model, working with UCSF from the outset. The press release does not disclose the project's cost, timeline, or scope. Suffolk cited prior California higher education and design-build work, including the UCSF Parnassus Heights site improvements.STATI studied Reddit forums on menopause — and found what doctors are missingAn author compares discussions of menopause and perimenopause symptoms on Reddit with more than 2 million electronic health record notes from the University of California, San Francisco, published in JAMA Network Open. Women discussed emotional well-being nearly three times as often as in clinical records, and cognitive symptoms nearly four times as often. The author argues clinicians should ask broader questions and that online conversations can reveal symptoms and experiences not captured in medical records.MorningstarSuffolk and CO Architects Selected to Deliver University of California, San Francisco Mission Bay Education Center and Dental Clinics ProjectSuffolk and CO Architects were selected to deliver the UCSF Mission Bay Education Center and Dental Clinics project via a progressive design-build model. The partnership will create new educational, clinical, and collaborative spaces to support dental education, research, and patient care. The project aims to integrate cutting-edge technologies and adaptable learning environments.Business Wire BlogSuffolk and CO Architects Selected to Deliver University of California, San Francisco Mission Bay Education Center and Dental Clinics ProjectSuffolk and CO Architects were selected to deliver the University of California, San Francisco Mission Bay Education Center and Dental Clinics project using a progressive design-build delivery model, working with UCSF from the outset. The facility will create new educational, clinical and collaborative spaces for dental education, research and patient care. No cost, schedule or timeline details were disclosed.FierceBiotechResearch into protein interactions sheds new light on causes of autismScientists at the University of California, San Francisco published a study in Science on Aug. 27 mapping over 1,800 protein interactions across 100 autism risk genes, with 87% previously unreported. Using AlphaFold, they found that a FOXP1 mutation interacting with FOXP4 produced autism-like traits in organoid models, rescued when FOXP4 was deleted. Krogan, director of the Quantitative Biosciences Institute, is in talks with Big Pharma to build a drug discovery platform.AijournJocasta Signs UCSF Licensing Agreement to Advance α-klotho for Managing Cognitive ImpairmentJocasta Neuroscience, Inc. has entered into a licensing agreement with the University of California, San Francisco (UCSF) to develop therapeutics based on α-klotho aimed at enhancing cognitive function. The agreement expands upon a previous license Jocasta acquired from Unity Biotechnology and grants exclusive rights to α-klotho-related intellectual property held by UCSF, specifically for neurodegenerative diseases. Jocasta plans to initiate Phase 1 human trials of its lead candidate, JN-0413, at the start of 2027.